Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.

[1]  Hong Wen,et al.  Association Between Uric Acid and N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Unstable Angina Pectoris. , 2020, The American journal of the medical sciences.

[2]  Shixiang Wang,et al.  Sex differences in uric acid and NT-pro BNP assessments during coronary severity , 2020, Medicine.

[3]  S. Han,et al.  Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP , 2017, PloS one.

[4]  I. Goldenberg,et al.  Prognostic value of ejection fraction in patients admitted with acute coronary syndrome , 2017, Medicine.

[5]  M. Sabatine,et al.  Multimarker Risk Stratification in Patients With Acute Myocardial Infarction , 2016, Journal of the American Heart Association.

[6]  Jeroen J. Bax,et al.  Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[7]  E. Bonora,et al.  Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes , 2016, Journal of Endocrinological Investigation.

[8]  Min Li,et al.  Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis , 2016, Scientific Reports.

[9]  M. Becker,et al.  Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease , 2015, Current medical research and opinion.

[10]  M. Volpe,et al.  Natriuretic peptides in cardiovascular diseases: current use and perspectives. , 2014, European heart journal.

[11]  Y. Huang,et al.  Uric acid and risk of heart failure: a systematic review and meta‐analysis , 2014, European journal of heart failure.

[12]  B. Afşar,et al.  The role of uric acid in the pathogenesis of human cardiovascular disease , 2013, Heart.

[13]  E. Picano,et al.  Comparison of prognostic value of echographic [corrected] risk score with the Thrombolysis in Myocardial Infarction (TIMI) and Global Registry in Acute Coronary Events (GRACE) risk scores in acute coronary syndrome. , 2010, The American journal of cardiology.

[14]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[15]  Duk-Hee Kang,et al.  Uric acid and cardiovascular risk. , 2008, The New England journal of medicine.

[16]  Jong Chun Park,et al.  N-terminal pro-B-type natriuretic Peptide predicts significant coronary artery lesion in the unstable angina patients with normal electrocardiogram, echocardiogram, and cardiac enzymes. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[17]  A. D. de Bold,et al.  Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. , 2004, Journal of molecular and cellular cardiology.

[18]  Salim Yusuf,et al.  The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. , 2002, Journal of the American College of Cardiology.